Patents by Inventor Emilia Albesiano

Emilia Albesiano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia
    Patent number: 9745364
    Abstract: This invention provides an anti-idiotype antibody that binds to the antigen-binding region of an antibody encoded by antibody genes selected from the group consisting of Set I, Set II, Set III, Set IV, Set V, Set VIa, Set VIb, Set VIc, Set VId, Set VIe, Set VII, and Set VIII, hybridomas and methods of treatments using such.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: August 29, 2017
    Assignee: The Feinstein Institute for Medical Research
    Inventors: Bradley T. Messmer, Nicholas Chiorazzi, Emilia Albesiano
  • METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA
    Publication number: 20120141462
    Abstract: This invention provides an anti-idiotype antibody that binds to the antigen-binding region of an antibody encoded by antibody genes selected from the group consisting of Set I, Set II, Set III, Set IV, Set V, Set VIa, Set VIb, Set VIc, Set VId, Set VIe, Set VII, and Set VIII, hybridomas and methods of treatments using such.
    Type: Application
    Filed: January 20, 2012
    Publication date: June 7, 2012
    Inventors: Bradley T. Messmer, Nicholas Chiorazzi, Emilia Albesiano
  • Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia
    Patent number: 8119340
    Abstract: Provided are isolated and purified preparations of a combination of a light chain antibody gene and a heavy chain antibody gene, where the light chain and heavy chain antibody genes are the same among more than one patient with B cell chronic lymphocytic leukemia (B-CLL). Vectors comprising those genes and cells comprising those vectors are also provided, as are isolated and purified antibodies encoded by the antibody genes. Anti-idiotype antibodies, peptides, and aptamers that bind to the antigen-binding region of an antibody encoded by the antibody genes are additionally provided, as are multimeric molecules comprising multiple binding sites that bind to the antigen-binding region of an antibody encoded by the antibody genes.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: February 21, 2012
    Assignee: The Feinstein Institute for Medical Research
    Inventors: Bradley T. Messmer, Nicholas Chiorazzi, Emilia Albesiano
  • Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
    Publication number: 20090117095
    Abstract: Provided are isolated and purified preparations of a combination of a light chain antibody gene and a heavy chain antibody gene, where the light chain and heavy chain antibody genes are the same among more than one patient with B cell chronic lymphocytic leukemia (B-CLL). Vectors comprising those genes and cells comprising those vectors are also provided, as are isolated and purified antibodies encoded by the antibody genes. Anti-idiotype antibodies, peptides, and aptamers that bind to the antigen-binding region of an antibody encoded by the antibody genes are additionally provided, as are multimeric molecules comprising multiple binding sites that bind to the antigen-binding region of an antibody encoded by the antibody genes.
    Type: Application
    Filed: October 8, 2004
    Publication date: May 7, 2009
    Inventors: Bradley T. Messmer, Nicholas Chiorazzi, Emilia Albesiano